Skip to main content
Clinical Trials/ITMCTR2000004129
ITMCTR2000004129
Not yet recruiting
Phase 1

A clinical study on the treatment of generalized anxiety disorder with the

West China Hospital, Sichuan University0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
West China Hospital, Sichuan University
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
West China Hospital, Sichuan University

Eligibility Criteria

Inclusion Criteria

  • 1\. MEET the diagnostic criteria of GAD in CCMD\-3;
  • 2\. The age should be 18\-75 years old;
  • 3\. Hamilton Anxiety Scale (HAMA) score \>\=14;
  • 4\. Patients who receive and adhere to western medicine or acupuncture treatment;
  • 5\. Sign the informed consent.

Exclusion Criteria

  • 1\. Secondary anxiety of somatic diseases, drug withdrawal reaction, and secondary anxiety of other mental diseases;
  • 2\. Pregnant and lactating women with severe cardiopulmonary, liver and kidney dysfunction;
  • 3\. History of organic brain disease and serious mental illness;
  • 4\. Those who are receiving systematic psychological treatment;
  • 5\. Those who have failed to respond to previous treatment with paroxetine or are allergic;
  • 6\. There is inflammation, scar or trauma at the site of operation, or other severe systemic infection.

Outcomes

Primary Outcomes

Not specified

Similar Trials